| European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study … M Fassnacht, OM Dekkers, T Else, E Baudin, A Berruti, RR De Krijger, ... European journal of endocrinology 179 (4), G1-G46, 2018 | 858 | 2018 |
| A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 CGP Mathew, KS Chin, DF Easton, K Thorpe, C Carter, GI Liou, SL Fong, ... Nature 328 (6130), 527-528, 1987 | 561 | 1987 |
| Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A Berruti, E Baudin, H Gelderblom, HR Haak, F Porpiglia, M Fassnacht, ... Annals of oncology 23, vii131-vii138, 2012 | 421 | 2012 |
| Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients HR Haak, J Hermans, CJH Van de Velde, E Lentjes, BM Goslings, ... British journal of cancer 69 (5), 947-951, 1994 | 393 | 1994 |
| Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ... The lancet oncology 16 (4), 426-435, 2015 | 364 | 2015 |
| Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection F Beuschlein, J Weigel, W Saeger, M Kroiss, V Wild, F Daffara, R Libé, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 841-849, 2015 | 359 | 2015 |
| Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis LV van de Poll‐Franse, S Houterman, MLG Janssen‐Heijnen, ... International journal of cancer 120 (9), 1986-1992, 2007 | 352 | 2007 |
| Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993 TMA Kerkhofs, RHA Verhoeven, JM Van der Zwan, J Dieleman, ... European Journal of Cancer 49 (11), 2579-2586, 2013 | 348 | 2013 |
| Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up M Fassnacht, G Assie, E Baudin, G Eisenhofer, C De La Fouchardiere, ... Annals of oncology 31 (11), 1476-1490, 2020 | 340 | 2020 |
| Identification of virilizing adrenal tumors in hirsute women J Derksen, SK Nagesser, AE Meinders, HR Haak, C van de Velde New England Journal of Medicine 331 (15), 968-973, 1994 | 291 | 1994 |
| Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study R Ruiter, LE Visser, MPP van Herk-Sukel, JWW Coebergh, HR Haak, ... Diabetes care 35 (1), 119-124, 2012 | 282 | 2012 |
| Quality and quantity of sleep and factors associated with sleep disturbance in hospitalized patients HM Wesselius, ES Van Den Ende, J Alsma, JC Ter Maaten, SCE Schuit, ... JAMA internal medicine 178 (9), 1201-1208, 2018 | 274 | 2018 |
| Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial N Alam, E Oskam, PM Stassen, P van Exter, PM van de Ven, HR Haak, ... The Lancet Respiratory Medicine 6 (1), 40-50, 2018 | 269 | 2018 |
| Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study R Libe, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ... Annals of Oncology 26 (10), 2119-2125, 2015 | 252 | 2015 |
| Plasma concentrations of o, p′ DDD, o, p′ DDA, and o, p′ DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@ T … IG Hermsen, M Fassnacht, M Terzolo, S Houterman, J Den Hartigh, ... The Journal of Clinical Endocrinology & Metabolism 96 (6), 1844-1851, 2011 | 204 | 2011 |
| Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry O Husson, HR Haak, LM Buffart, WA Nieuwlaat, WA Oranje, F Mols, ... Acta oncologica 52 (2), 249-258, 2013 | 182 | 2013 |
| Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study I Bancos, AE Taylor, V Chortis, AJ Sitch, C Jenkinson, CJ Davidge-Pitts, ... The lancet Diabetes & endocrinology 8 (9), 773-781, 2020 | 181 | 2020 |
| Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer A Berruti, M Fassnacht, H Haak, T Else, E Baudin, P Sperone, M Kroiss, ... European urology 65 (4), 832-838, 2014 | 167 | 2014 |
| Health‐related quality of life among thyroid cancer survivors: a systematic review O Husson, HR Haak, WA Oranje, F Mols, PHM Reemst, ... Clinical endocrinology 75 (4), 544-554, 2011 | 166 | 2011 |
| Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection M Terzolo, AE Baudin, A Ardito, M Kroiss, S Leboulleux, F Daffara, ... European journal of endocrinology 169 (3), 263-270, 2013 | 163 | 2013 |
